CL2023000315A1 - Composición farmacéutica de corticosteroide intraarticular para el control del dolor - Google Patents

Composición farmacéutica de corticosteroide intraarticular para el control del dolor

Info

Publication number
CL2023000315A1
CL2023000315A1 CL2023000315A CL2023000315A CL2023000315A1 CL 2023000315 A1 CL2023000315 A1 CL 2023000315A1 CL 2023000315 A CL2023000315 A CL 2023000315A CL 2023000315 A CL2023000315 A CL 2023000315A CL 2023000315 A1 CL2023000315 A1 CL 2023000315A1
Authority
CL
Chile
Prior art keywords
intra
pharmaceutical composition
articular corticosteroid
pain control
articular
Prior art date
Application number
CL2023000315A
Other languages
English (en)
Spanish (es)
Inventor
Shih Sheue-Fang
Oscar Brown Carl
Original Assignee
Tlc Biopharmaceuticals Inc
Taiwan Liposome Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tlc Biopharmaceuticals Inc, Taiwan Liposome Co Ltd filed Critical Tlc Biopharmaceuticals Inc
Publication of CL2023000315A1 publication Critical patent/CL2023000315A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CL2023000315A 2020-08-05 2023-02-01 Composición farmacéutica de corticosteroide intraarticular para el control del dolor CL2023000315A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063061395P 2020-08-05 2020-08-05

Publications (1)

Publication Number Publication Date
CL2023000315A1 true CL2023000315A1 (es) 2023-09-22

Family

ID=77519828

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2023000315A CL2023000315A1 (es) 2020-08-05 2023-02-01 Composición farmacéutica de corticosteroide intraarticular para el control del dolor

Country Status (13)

Country Link
US (1) US12514820B2 (https=)
EP (1) EP4192426A1 (https=)
JP (1) JP2023537474A (https=)
KR (1) KR20230048066A (https=)
CN (1) CN116348093A (https=)
AU (1) AU2021320774A1 (https=)
BR (1) BR112023001926A2 (https=)
CA (1) CA3187955A1 (https=)
CL (1) CL2023000315A1 (https=)
IL (1) IL300354A (https=)
MX (1) MX2023001410A (https=)
TW (1) TW202220668A (https=)
WO (1) WO2022031898A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2854769T1 (sl) * 2012-07-05 2023-09-29 Taiwan Liposome Company, Ltd. Postopki za zdravljenje artritisa
ES2985871T3 (es) * 2017-03-14 2024-11-07 Seikagaku Kogyo Co Ltd Composición para tratar artropatías y kit que incluye la misma
EP3849522A1 (en) * 2018-09-16 2021-07-21 TLC Biopharmaceuticals, Inc. Pharmaceutical compositions suitable for articular delivery and use thereof in treatment of joint pain

Also Published As

Publication number Publication date
EP4192426A1 (en) 2023-06-14
TW202220668A (zh) 2022-06-01
KR20230048066A (ko) 2023-04-10
IL300354A (en) 2023-04-01
US20230285293A1 (en) 2023-09-14
JP2023537474A (ja) 2023-09-01
CN116348093A (zh) 2023-06-27
US12514820B2 (en) 2026-01-06
AU2021320774A1 (en) 2023-03-09
WO2022031898A1 (en) 2022-02-10
CA3187955A1 (en) 2022-02-10
BR112023001926A2 (pt) 2023-03-07
MX2023001410A (es) 2023-03-06

Similar Documents

Publication Publication Date Title
CL2019003542A1 (es) Métodos de tratamiento para la fibrosis quística.
MX2022005994A (es) Uso del inhibidor de fak en la preparacion de un farmaco para el tratamiento contra tumores con mutacion nras.
PE20242299A1 (es) Composiciones agonistas de gip/glp1
MX2015017307A (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington.
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
MX2022000143A (es) Metodos novedosos.
EA200870469A1 (ru) Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение
AR127247A1 (es) Inhibidores de cdk2 de ciclopentilpirazol
PE20250835A1 (es) Composiciones y uso de la tirzepatida
EA202190544A1 (ru) Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний
AR119033A1 (es) Métodos para tratar cánceres asociados con virus con inhibidores de la histona deacetilasa
CL2024003729A1 (es) Terapia combinada de agente activo anti-pd-1, agente activo anti-tim-3 y agente activo anti-lag-3 para tratar cáncer.
BR112022025920A2 (pt) Tratamento de artrite reumatoide
CL2023000315A1 (es) Composición farmacéutica de corticosteroide intraarticular para el control del dolor
CO2026000726A2 (es) Una forma farmacéutica sólida de dosificación bucodispersable de safinamida
MX2021003030A (es) Composiciones farmaceuticas adecuadas para suministro articular y su uso en tratamiento de dolor de articulacion.
CO2025007025A2 (es) Formulaciones orales compactables de ibutamoren
AR132497A1 (es) Combinación de obicetrapib amorfo e inhibidor de sglt2
MX2025000682A (es) Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma
CL2021003303A1 (es) Tratamiento para sinucleinopatías.
AR101227A1 (es) Combinaciones de un derivado de n-tiazolil-4-fenoxibencenosulfonamida y un agente farmacéuticamente activo seleccionado a partir de gabapentina y pregabalina para tratar dolor
BR112022019493A2 (pt) Cocristal de gabapentina, cetoprofeno e lisina, composições farmacêuticas e seu uso médico
MX2023013514A (es) Metodos para tratar la cistitis intersticial/sindrome de dolor en la vejiga.
RU2015114709A (ru) Стабильная композиция для инъекций, содержащая диклофенак и тиоколхикозид
AR128870A1 (es) Inhibidores de tyk2 y usos de los mismos